Mortality and hospitalization risks in patients with cancer and the SARS-CoV-2 Omicron variant

About The Study: This study showed that during the Omicron-dominant period, patients with solid cancer and COVID-19 had higher mortality and hospitalization risks following COVID-19 infection versus patients without solid cancer with COVID-19, and that COVID-19 vaccination in the patients with cancer mitigated this risk. 

Authors: Salomon M. Stemmer, M.D., of Beilinson Hospital in Petah Tikva, Israel, is the corresponding author. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2023.5042)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.5042?guestAccessKey=0a3448f5-6aba-4a06-9565-e90c4721059c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112223

 

END